Canada vs Kazakhstan: Cause of death, by non-communicable diseases, ages 0-4, male
Canada
41.0%
in 2021
Kazakhstan
40.9%
in 2021
Canada rank
39th
Kazakhstan rank
41st
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Canada
- Kazakhstan
How they compare
Canada currently reports 41.0% against 40.9% in Kazakhstan, a difference of 0.1%.
Across all 6 years both countries report, Canada has been ahead every year.
Canada ranks 39th and Kazakhstan ranks 41st of 185 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.2% | 18.8% | 25.4% | Canada |
| 2010s | 42.0% | 37.6% | 4.4% | Canada |
| 2020s | 41.1% | 41.0% | 0.1% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Canada or Kazakhstan?
- Canada, at 41.0% against 40.9% in Kazakhstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Canada and Kazakhstan?
- 0.1%, with Canada ahead.
- How many years of comparable data are there for Canada and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Canada and Kazakhstan rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Canada ranks 39th and Kazakhstan ranks 41st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.